Literature DB >> 7594095

Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finnish cohorts of the Seven Countries Study.

M Tervahauta1, J Pekkanen, A Nissinen.   

Abstract

OBJECTIVES: We attempted to determine whether elevated levels of the classic coronary heart disease risk factors are associated with increased coronary risk and all-cause mortality among elderly men with and without coronary heart disease at baseline.
BACKGROUND: The strength of any association between the classic coronary risk factors and survival among elderly men with and without coronary heart disease has not been established.
METHODS: The classic coronary risk factor levels and risk of coronary events and total mortality during a 5-year follow-up interval were studied among men aged 65 to 84 years. Coronary events were fatal myocardial infarction (n = 71), any myocardial infarction (n = 96) and, among the men without disease, other nonfatal coronary heart disease events (n = 80).
RESULTS: Among the 171 men with prevalent coronary heart disease, significant (p < 0.05) risk factors for fatal myocardial infarction (n = 42) in multivariate analyses were low high density lipoprotein cholesterol (odds ratio [OR] 0.2, 95% confidence interval [CI] 0.1 to 0.8 for 1-mmol/liter increase), high ratio of total to high density lipoprotein cholesterol (OR 1.4, 95% CI 1.1 to 1.7 for 1-U increase), and smoking more than nine cigarettes daily (OR 6.0, 95% CI 1.5 to 24.9 vs. values in men who had never smoked). Among the 476 men without prevalent coronary heart disease, only high serum total cholesterol was a risk factor for fatal myocardial infarction (n = 29) (OR 1.4, 95% CI 1.0 to 2.0 for 1-mmol/liter increase). Among men with prevalent coronary heart disease, the only significant (p < 0.05) risk factor for total mortality was smoking more than nine cigarettes daily (OR 3.9, 95% CI 1.1 to 13.4 vs. values among men who had never smoked). Among men without prevalent coronary heart disease, only the use of antihypertensive medication (OR 2.0, 95% CI 1.2 to 3.3 between men with and without such medication) was a risk factor for total mortality.
CONCLUSIONS: The classic risk factors for coronary heart disease appear to be of importance even in old age, especially among men with prevalent coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594095     DOI: 10.1016/0735-1097(95)00395-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Summary of scientific evidence.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  2002-02

2.  Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.

Authors:  C Sanderson; M Kubin
Journal:  Health Care Manag Sci       Date:  2001-12

3.  A dose-response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality.

Authors:  L Liu; M Han; R Qie; Q Li; X Zhang; J Zhang; S Zhan; L Zhang; Z Xu; C Zhang; F Hong
Journal:  J Endocrinol Invest       Date:  2021-10-21       Impact factor: 4.256

4.  Does folate therapy reduce the risk of coronary restenosis?

Authors:  E S van Hattum; P A Doevendans; F L Moll
Journal:  Neth Heart J       Date:  2007-01       Impact factor: 2.380

5.  Smoking and risk of all-cause mortality: the Jichi Medical School (JMS) Cohort Study.

Authors:  Fumihiro Uno; Shizukiyo Ishikawa; Yosikazu Nakamura; Tadao Gotoh; Naoki Nago; Kazunori Kayaba; Eiji Kajii
Journal:  J Epidemiol       Date:  2005-09       Impact factor: 3.211

6.  Improvements in the metabolic syndrome and stages of change for lifestyle behaviors in korean older adults.

Authors:  Seunghyun Yoo; Hyekyeong Kim; Han-Ik Cho
Journal:  Osong Public Health Res Perspect       Date:  2012-06

7.  Lipid profile and prognosis in patients with coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Xiangmei Zhao; Dongying Wang; Lijie Qin
Journal:  BMC Cardiovasc Disord       Date:  2021-02-03       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.